Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer

By K. Haratani, H. Hayashi, Y. Chiba, K. Kudo, K. Yonesaka, R. Kato, H. Kaneda, Y. Hasegawa, Kaoru Tanaka, M. Takeda and 1 more. JAMA Oncology, 2017

922 citations recorded by the source corpus.